LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Recalls and defects › 2 Jun 2026
Medicines recall

ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators

Issued on 2 Jun 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Class 2 recall
Check the batch number on the pack. The medicine remains licensed; other batches are not affected.
Class 2 recall · DMRC - 39617055 · PL: 05920/0002 · licence holder: Becton Dickinson UK Ltd · active ingredient: chlorhexidine gluconate 2%w/v and isopropyl alcohol 70% v/v · licence PL: 05920/0002

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 2 recall · DMRC - 39617055

ProductLicenceActive ingredientGTIN
ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicatorsPL: 05920/0002chlorhexidine gluconate 2%w/v and isopropyl alcohol 70% v/v20885403491761

Background: Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators and ChloraPrep Frepp 2% w/v / 70% v/v cutaneous solution 1.5 mL applicators due to a potential breach of sterility in the packaging process. The recall applies to all batches with an expiry date up to and including 02/2028. Batches with an expiry date after 02/2028 are not impacted. This defect could increase the risk of the applicator device being contaminated with pathogens, which could lead to increased infection rates for the patients. The number of impacted units in each batch is unknown, therefore the batches included in Annex 1 are being recalled as a precautionary measure. The full list of impacted batch details is included in Annex 1.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.